Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
European Journal of Medicinal Chemistry|May 14, 2020
Novel bacterial topoisomerase inhibitors derived from isomannideAntony Okumu, Yanran Lu, Sheri Dellos-Nolan, et al.
ACS Medicinal Chemistry Letters|December 18, 2020
Dioxane-Linked Amide Derivatives as Novel Bacterial Topoisomerase Inhibitors against Gram-Positive <i>Staphylococcus aureus</i>Yanran Lu, Jonathan L Papa, Sheri Nolan, et al.
Journal of Medicinal Chemistry|October 19, 2025
Development of Selective and Soluble Mitochondrial Complex 1 Inhibitors Derived from Papaverine for Radiosensitization of CancerBen J Haines, McKenzie Kreamer, Martin Benej, et al.
ACS Infectious Diseases|January 10, 2025
Anti-Mycobacterial Activity of Bacterial Topoisomerase Inhibitors with Dioxygenated LinkersMark J Mitton-Fry, Jason E Cummings, Yanran Lu, et al.
ACS Medicinal Chemistry Letters|August 14, 2024
Development of Novel Bacterial Topoisomerase Inhibitors Assisted by Computational ScreeningJoshua W Powell, Chelsea A Mann, Paul D Toth, et al.
ACS Infectious Diseases|December 23, 2025
Activities of the Novel Bacterial Topoisomerase Inhibitor OSUAB-0284 against the Biothreat Pathogen <i>Bacillus anthracis</i> and Its Type II TopoisomerasesChelsea A Mann, Stephanie A Halasohoris, Annette M Gray, et al.
ACS Infectious Diseases|May 2, 2019
1,3-Dioxane-Linked Bacterial Topoisomerase Inhibitors with Enhanced Antibacterial Activity and Reduced hERG InhibitionLinsen Li, Antony A Okumu, Sheri Nolan, et al.
ACS Medicinal Chemistry Letters|June 16, 2022
1,3-Dioxane-Linked Novel Bacterial Topoisomerase Inhibitors: Expanding Structural Diversity and the Antibacterial SpectrumYanran Lu, Chelsea A Mann, Sheri Nolan, et al.
Journal of Medicinal Chemistry|October 6, 2021
Optimization of TopoIV Potency, ADMET Properties, and hERG Inhibition of 5-Amino-1,3-dioxane-Linked Novel Bacterial Topoisomerase Inhibitors: Identification of a Lead with <i>In Vivo</i> Efficacy against MRSAYanran Lu, Sandip Vibhute, Linsen Li, et al.
Bioorganic & Medicinal Chemistry Letters|June 15, 2017
Novel 3-fluoro-6-methoxyquinoline derivatives as inhibitors of bacterial DNA gyrase and topoisomerase IVMark J Mitton-Fry, Steven J Brickner, Judith C Hamel, et al.
Pageof 3